Published in Cancer Weekly, July 14th, 1997
Peritoneal dissemination is a common complication of cancers of the digestive tract. Unfortunately, patients who have reached this point often have metastases that are refractory to existing chemo-, radio-, endocrine, and/or immune therapies. Potent therapeutics are desperately needed.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.